Today: 9 April 2026
Subscribe

Artiva Biotherapeutics (ARTV) Stock Skyrockets on FDA Fast Track News – What’s Next for Investors?

Artiva Biotherapeutics (ARTV) Stock Skyrockets on FDA Fast Track News – What’s Next for Investors?

Artiva Biotherapeutics shares surged nearly 100% in after-hours trading Oct. 16 after the FDA granted Fast Track status to its AlloNK cell therapy for refractory rheumatoid arthritis. The stock jumped from a $2.77 close to as high as $6.33. Over 20 patients have received AlloNK in trials, with key safety and mechanistic data expected by mid-November. Artiva plans to begin a pivotal Phase 3 trial in 2026, pending results.
17 October 2025
·
Truist’s Q3 Earnings Beat and 5% Dividend Yield Trigger Rally as Analysts Grow Bullish

Truist’s Q3 Earnings Beat and 5% Dividend Yield Trigger Rally as Analysts Grow Bullish

Truist Financial reported Q3 earnings of $1.04 per share, beating estimates, with net income rising to $1.35 billion on $5.24 billion revenue. Shares jumped 4% after results but remain down 5.3% year-to-date. Fee income surged 11% sequentially, offsetting flat net interest income. The bank maintained its $0.52 dividend and repurchased $500 million in stock.
17 October 2025
···
Reliance Q2 Results Boost Investor Hopes – Double-Digit Growth, Jio IPO Buzz & Stock Breakout?

Reliance Q2 Results Boost Investor Hopes – Double-Digit Growth, Jio IPO Buzz & Stock Breakout?

Reliance Industries is expected to report Q2 FY26 net profit of ₹18,000–21,000 crore, up about 10% year-on-year, with revenue rising to ₹2.52–2.57 lakh crore. The gains are driven by strong oil-to-chemicals margins and growth in Jio and retail. The stock has rebounded 4% in October after a post-Q1 drop. Investors await updates on a potential Jio IPO and progress in new energy and AI initiatives.
17 October 2025
····
Big Pharma’s Billion-Dollar Bet: Inside Eli Lilly’s $5B Virginia Factory and America’s New Drug Manufacturing Boom

Eli Lilly (LLY) Surges on Obesity Drug Boom and Alzheimer’s Breakthroughs – Is $1,000 Next?

Eli Lilly shares hit a record $832 intraday on Oct. 1, fueled by demand for its obesity drugs and Alzheimer’s advances, before slipping 4% after Donald Trump pledged to cut weight-loss drug prices. Lilly’s Mounjaro and ZepBound now hold 57% of U.S. GLP-1 prescriptions, outpacing Novo Nordisk. First-half 2025 revenue jumped about 40% year-on-year. Most analysts remain bullish, despite valuation and policy concerns.
17 October 2025
··
Bank of America (BAC) Stock Soars on Earnings Beat – Can It Keep Climbing?

Bank of America (BAC) Stock Soars on Earnings Beat – Can It Keep Climbing?

Bank of America shares traded near $50 midday Friday, down about 1.5% after a 3.5% drop Thursday erased post-earnings gains. The bank reported Q3 net income of $8.5 billion and revenue of $28.1 billion, both above estimates. BAC raised its Q4 net interest income outlook and boosted its dividend. Analyst price targets rose after earnings, with the average 12-month target at $56.
17 October 2025
··
Palantir’s Shocking Reinvention: From Secretive Spy Tech to $400B Cult Lifestyle Brand

Palantir (PLTR) Stock Soars 300% on AI Mega-Deals – Boom or Bubble Ahead?

Palantir shares traded near $178–$180 on October 17, 2025, up 300% year-to-date and just below August’s record high. The surge follows major AI contracts, including a $10 billion U.S. Army deal and a new partnership with Snowflake. Q2 revenue rose 48% to $1.03 billion, with profit at $327 million. At $180 per share, Palantir’s valuation exceeds $425 billion, drawing both bullish targets and warnings of a bubble.
17 October 2025
···
Solana’s $195 Lifeline: Can Bulls Turn This Dip Into a $250+ Comeback Rally?

Solana’s $195 Lifeline: Can Bulls Turn This Dip Into a $250+ Comeback Rally?

Solana’s price has dropped to around $186–$195 after peaking above $250 in early October, testing a key support zone. Nearly $400 million in SOL left exchanges in recent days, signaling heavy profit-taking and reduced liquidity. Andreessen Horowitz invested $50 million in a Solana staking firm, while Forward Industries raised $1.65 billion to buy SOL. Analysts see $186–$195 as critical; failure to hold could send SOL toward $172 or lower.
17 October 2025
·
SoFi’s Roller-Coaster Rally: Fintech Stock Soars 230% in 2025 – What’s Next for SOFI?

SoFi’s Roller-Coaster Rally: Fintech Stock Soars 230% in 2025 – What’s Next for SOFI?

SoFi shares surged 230% over the past year, hitting a 52-week high of $30.30 in late September before dropping to $26.60 on Oct. 16. The company will report Q3 earnings on Oct. 28, with analysts expecting EPS of $0.08 on $880 million in revenue. SoFi recently launched fee-free options trading and an AI-focused ETF, and plans to enable crypto payments by late 2025. CEO changes and student loan policy developments are also in focus.
17 October 2025
··
INVO Fertility (IVF) Stock’s Wild 90% Surge Amid IVF Boom – What’s Behind the Frenzy?

INVO Fertility (IVF) Stock’s Wild 90% Surge Amid IVF Boom – What’s Behind the Frenzy?

INVO Fertility shares jumped nearly 90% to $1.43 on Oct. 16, 2025, with volume topping 108 million amid a sector rally sparked by White House plans to expand IVF access. The stock briefly surpassed $2 before dropping about 30% early the next day as traders took profits. INVO raised $200,000 in a preferred share sale and filed to register 8.35 million shares for resale. The company remains unprofitable and cash-strapped.
17 October 2025
·
Amazon Stock Today: AI Ambitions, $2.5B Twist, and $3 Trillion Dreams

Amazon Stock Rebound Stalls: AI Ambitions, $2.5B Settlement & the $3 Trillion Question

Amazon shares traded near $214 on Oct. 17 after falling almost 5% from $228 last week during a tech sector sell-off. Year-to-date, the stock is up about 3%, trailing the Nasdaq’s 15% gain. The company recently settled an FTC probe for $2.5 billion and announced new AI initiatives, but remains roughly 10% below its February 2025 high.
17 October 2025
····
Novo Nordisk’s $5.2 Billion Bet to Reverse Fatty Liver Disease – Game-Changer or Big Gamble?

Novo Nordisk’s Weight-Loss Crown at Risk? NVO Stock Slumps Amid Surprise Deals – What’s Next

Novo Nordisk shares fell 6.7% in Copenhagen on Oct. 17, 2025, and U.S. pre-market quotes pointed to a further 4.8% drop. The stock has lost over 40% year-to-date, erasing hundreds of billions in value. Recent acquisitions and job cuts have not reversed investor caution, as competition from Eli Lilly intensifies and analysts warn of more profit downgrades.
17 October 2025
··
Oracle’s ‘Truly Awesome’ AI Cloud Quarter Sends Stock Soaring 36%, Making Ellison World’s Richest

Oracle’s $300B AI Cloud Bet Sends Stock Soaring – Trillion-Dollar Dreams Awaken

Oracle shares surged over 36% on September 10, 2025, after announcing $300 billion in new AI cloud contracts, including a major deal with OpenAI. The stock hit an all-time high near $345, then pulled back on margin concerns but remains up about 70–80% year-to-date. Fiscal Q1 revenue rose 12% to $14.93 billion, driven by 28% cloud growth. Oracle’s backlog soared to $455 billion, up 359% from a year earlier.
17 October 2025
···
Apple’s July 2025 Bombshells: Foldable iPhone, AI Secrets, Encryption Showdown & More

Apple Stock Surges on New Products and iPhone 17 “Supercycle” – Analysts Split on AAPL’s Next Move

Apple shares hovered near $247–$249 this week, just below their record high. On Oct. 15, Apple launched new M5 chip devices, including a refreshed MacBook Pro and Vision Pro headset, without raising prices. Early iPhone 17 sales are running 10–15% above last year’s launch. CEO Tim Cook remains, but succession plans are in motion, with John Ternus seen as a likely successor.
17 October 2025
··
Nvidia’s $4 Trillion AI Stock Surge: Record Highs, Mega Deals & Bold Forecasts

Nvidia Stock Whipsaws as AI Boom Clashes with New Risks

Nvidia shares hovered near $182 on October 17 after swinging from a record $195 earlier in the month. Surging AI chip demand pushed last quarter’s revenue up 56% to $46.7 billion, with data-center sales at $41 billion. AMD’s recent chip wins and U.S.–China trade tensions have raised concerns. Nvidia reports earnings November 19; most analysts remain bullish with price targets above $210.
17 October 2025
··
AST SpaceMobile (ASTS) Stock Skyrockets on Verizon Deal – Is Satellite-to-Phone Broadband the Next Big Thing?

AST SpaceMobile Stock Shoots for the Stars on Verizon Deal – What’s Next for ASTS?

AST SpaceMobile stock hit an intraday record near $99 this week after announcing a Verizon partnership for space-based cellular service. Shares have surged over 300% in 2025, pushing the company’s market value to about $30 billion despite minimal revenue. Wall Street remains split on valuation, with short interest above 20%. ASTS is rapidly spending to build its satellite network and expects pilot revenues later this year.
17 October 2025
···
The $350B Shake-Up: How AI Summaries Rewire Publisher Traffic

Alphabet (GOOGL) Stock Soars on AI Boom & Ad Rebound – $3 Trillion Valuation in Sight?

Alphabet shares hovered near $252 on Oct. 17 after hitting a 52-week high of $256, lifting its market value to about $2.97 trillion. The stock is up over 30% in 2025, far outpacing the S&P 500. Q2 cloud revenue jumped 32% year-over-year, and ad sales rebounded sharply. Analysts remain bullish, though regulators in the U.S. and Europe have stepped up scrutiny.
17 October 2025
···
Zions Bancorp Stock Plunges 13% After Surprise $50M Fraud-Linked Loan Loss – Is More Trouble Ahead?

Fraud Scandals at U.S. Banks Wipe $100 Billion, Spur Global Selloff as ‘Cockroach’ Credit Fears Mount

Zions Bancorp disclosed a $50 million loan loss tied to alleged fraud, sending its shares down 13% and sparking a selloff that erased over $100 billion in U.S. bank market value. Western Alliance, exposed to the same borrowers, dropped 11%. Global bank stocks fell, gold hit a record above $4,370/oz, and Treasury yields plunged as credit fears spread. JPMorgan’s Jamie Dimon warned more loan problems may surface.
17 October 2025
······
1 … 1,653 1,654 1,655 1,656 1,657 … 1,847

Stock Market Today

  • Monmouth Real Estate Investment Corp (MNR) Stock Price and Analysis
    April 9, 2026, 5:29 PM EDT. Monmouth Real Estate Investment Corp (MNR) stock price performance reflects cumulative returns over one to four years from March 2017 to March 2021. The data excludes Spotify for some periods. Past returns do not guarantee future results. Gotrade Securities Inc., licensed under Labuan Financial Services and Securities Act 2010, provides this analysis. Investment risks include potential capital loss. This information is general and not personalized financial advice or an offer to buy or sell securities. It is not intended for residents of the United States or jurisdictions restricting such distribution.

Latest article

CoreWeave secures fresh $21 billion Meta AI deal as debt push raises stakes

CoreWeave secures fresh $21 billion Meta AI deal as debt push raises stakes

9 April 2026
Meta Platforms signed a new $21 billion deal with CoreWeave for AI cloud computing capacity through 2032, according to a securities filing. CoreWeave shares rose 3.4% in after-hours trading. The agreement adds to a $14.2 billion commitment disclosed last September. CoreWeave also launched $3 billion in convertible notes and upsized a senior-notes deal to $1.75 billion.
Tesla Revives Cheaper EV Push With New Compact SUV as Sales Pressure Builds

Tesla Revives Cheaper EV Push With New Compact SUV as Sales Pressure Builds

9 April 2026
Tesla is developing a lower-cost compact SUV, with initial production planned for Shanghai, Reuters reported Thursday. The company built 408,386 vehicles and delivered 358,023 in the first quarter, leaving its widest gap in at least four years. Reuters said the new SUV likely will not reach production this year. Tesla did not respond to questions about the project.
NIO ES9 Price Starts at 528,000 Yuan as Flagship SUV Bet Faces China EV Slump

NIO ES9 Price Starts at 528,000 Yuan as Flagship SUV Bet Faces China EV Slump

9 April 2026
NIO opened pre-orders for its ES9 flagship SUV Thursday, pricing it at 528,000 yuan with battery or 420,000 yuan under its Battery-as-a-Service plan. March deliveries rose 136% year-on-year, but NIO’s U.S. shares fell 4.9% after the announcement. The ES9 enters a shrinking premium SUV market in China, competing with Li Auto and Aito. CEO William Li warned chip shortages could add up to 10,000 yuan per vehicle.
Plug Power Stock Climbs After 2026 Profit Push, Up to $200M Cost-Cut Plan

Plug Power Stock Climbs After 2026 Profit Push, Up to $200M Cost-Cut Plan

9 April 2026
Plug Power shares rose 2.5% to $2.715 Thursday after the company reaffirmed its target of positive EBITDAS by end-2026 and projected up to $200 million in savings from Project Quantum Leap. The update followed a major electrolyzer project win in Quebec and investor meetings in Toronto and Montreal. Plug reported 2025 revenue of $710 million and a fourth-quarter gross profit of $5.5 million.
Oil Prices Today: Brent, WTI Rebound as Fragile Iran Ceasefire Leaves Hormuz Choked

Oil Prices Today: Brent, WTI Rebound as Fragile Iran Ceasefire Leaves Hormuz Choked

9 April 2026
Oil prices rebounded Thursday as traffic through the Strait of Hormuz stayed below 10% of normal, with just seven ships passing in 24 hours. Brent crude rose 1% to $95.65 a barrel, while U.S. WTI climbed 3.2% to $97.39. North Sea Forties crude hit a record $146.43. Major shippers and banks warned supply disruptions could persist for weeks despite the U.S.-Iran ceasefire.
Go toTop